Global Platinum-based Anticancer Drugs Market Research Report 2021

1 Platinum-based Anticancer Drugs Market Overview

• 1.1 Product Overview and Scope of Platinum-based Anticancer Drugs
• 1.2 Platinum-based Anticancer Drugs Segment by Type
  • 1.2.1 Global Platinum-based Anticancer Drugs Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Cisplatin
  • 1.2.3 Carboplatin
  • 1.2.4 Oxaliplatin
  • 1.2.5 Nedaplatin
  • 1.2.6 Others
• 1.3 Platinum-based Anticancer Drugs Segment by Application
  • 1.3.1 Platinum-based Anticancer Drugs Sales Comparison by Application: (2021-2027)
  • 1.3.2 Testicular Cancer
  • 1.3.3 Osteosarcoma
  • 1.3.4 Breast Cancer
  • 1.3.5 Esophageal Cancer
  • 1.3.6 NSCLC
  • 1.3.7 Other
• 1.4 Global Platinum-based Anticancer Drugs Market Size Estimates and Forecasts
  • 1.4.1 Global Platinum-based Anticancer Drugs Revenue 2016-2027
  • 1.4.2 Global Platinum-based Anticancer Drugs Sales 2016-2027
  • 1.4.3 Platinum-based Anticancer Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Platinum-based Anticancer Drugs Market Competition by Manufacturers

• 2.1 Global Platinum-based Anticancer Drugs Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Platinum-based Anticancer Drugs Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Platinum-based Anticancer Drugs Manufacturing Sites, Area Served, Product Type
• 2.5 Platinum-based Anticancer Drugs Market Competitive Situation and Trends
  • 2.5.1 Platinum-based Anticancer Drugs Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Platinum-based Anticancer Drugs Players Market Share by Revenue
  • 2.5.3 Global Platinum-based Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Platinum-based Anticancer Drugs Retrospective Market Scenario by Region

• 3.1 Global Platinum-based Anticancer Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Platinum-based Anticancer Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Platinum-based Anticancer Drugs Market Facts & Figures by Country
  • 3.3.1 North America Platinum-based Anticancer Drugs Sales by Country
  • 3.3.2 North America Platinum-based Anticancer Drugs Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Platinum-based Anticancer Drugs Market Facts & Figures by Country
  • 3.4.1 Europe Platinum-based Anticancer Drugs Sales by Country
  • 3.4.2 Europe Platinum-based Anticancer Drugs Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Platinum-based Anticancer Drugs Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Platinum-based Anticancer Drugs Sales by Region
  • 3.5.2 Asia Pacific Platinum-based Anticancer Drugs Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Platinum-based Anticancer Drugs Market Facts & Figures by Country
  • 3.6.1 Latin America Platinum-based Anticancer Drugs Sales by Country
  • 3.6.2 Latin America Platinum-based Anticancer Drugs Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Platinum-based Anticancer Drugs Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Platinum-based Anticancer Drugs Sales by Country
  • 3.7.2 Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Platinum-based Anticancer Drugs Historic Market Analysis by Type

• 4.1 Global Platinum-based Anticancer Drugs Sales Market Share by Type (2016-2021)
• 4.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2016-2021)
• 4.3 Global Platinum-based Anticancer Drugs Price by Type (2016-2021)

5 Global Platinum-based Anticancer Drugs Historic Market Analysis by Application

• 5.1 Global Platinum-based Anticancer Drugs Sales Market Share by Application (2016-2021)
• 5.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2016-2021)
• 5.3 Global Platinum-based Anticancer Drugs Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Sanofi-Aventis
  • 6.1.1 Sanofi-Aventis Corporation Information
  • 6.1.2 Sanofi-Aventis Description and Business Overview
  • 6.1.3 Sanofi-Aventis Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Sanofi-Aventis Product Portfolio
  • 6.1.5 Sanofi-Aventis Recent Developments/Updates
• 6.2 Yakult honsha
  • 6.2.1 Yakult honsha Corporation Information
  • 6.2.2 Yakult honsha Description and Business Overview
  • 6.2.3 Yakult honsha Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Yakult honsha Product Portfolio
  • 6.2.5 Yakult honsha Recent Developments/Updates
• 6.3 Dr Reddy's laboratories
  • 6.3.1 Dr Reddy's laboratories Corporation Information
  • 6.3.2 Dr Reddy's laboratories Description and Business Overview
  • 6.3.3 Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Dr Reddy's laboratories Product Portfolio
  • 6.3.5 Dr Reddy's laboratories Recent Developments/Updates
• 6.4 Sun Pharmaceutical
  • 6.4.1 Sun Pharmaceutical Corporation Information
  • 6.4.2 Sun Pharmaceutical Description and Business Overview
  • 6.4.3 Sun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Sun Pharmaceutical Product Portfolio
  • 6.4.5 Sun Pharmaceutical Recent Developments/Updates
• 6.5 Teva
  • 6.5.1 Teva Corporation Information
  • 6.5.2 Teva Description and Business Overview
  • 6.5.3 Teva Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Teva Product Portfolio
  • 6.5.5 Teva Recent Developments/Updates
• 6.6 Fresenius Kabi
  • 6.6.1 Fresenius Kabi Corporation Information
  • 6.6.2 Fresenius Kabi Description and Business Overview
  • 6.6.3 Fresenius Kabi Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Fresenius Kabi Product Portfolio
  • 6.6.5 Fresenius Kabi Recent Developments/Updates
• 6.7 Hospira(Pfizer)
  • 6.6.1 Hospira(Pfizer) Corporation Information
  • 6.6.2 Hospira(Pfizer) Description and Business Overview
  • 6.6.3 Hospira(Pfizer) Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Hospira(Pfizer) Product Portfolio
  • 6.7.5 Hospira(Pfizer) Recent Developments/Updates
• 6.8 Mylan
  • 6.8.1 Mylan Corporation Information
  • 6.8.2 Mylan Description and Business Overview
  • 6.8.3 Mylan Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Mylan Product Portfolio
  • 6.8.5 Mylan Recent Developments/Updates
• 6.9 Taj Pharmaceuticals
  • 6.9.1 Taj Pharmaceuticals Corporation Information
  • 6.9.2 Taj Pharmaceuticals Description and Business Overview
  • 6.9.3 Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Taj Pharmaceuticals Product Portfolio
  • 6.9.5 Taj Pharmaceuticals Recent Developments/Updates
• 6.10 Jiangsu Hengrui Medicine
  • 6.10.1 Jiangsu Hengrui Medicine Corporation Information
  • 6.10.2 Jiangsu Hengrui Medicine Description and Business Overview
  • 6.10.3 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Jiangsu Hengrui Medicine Product Portfolio
  • 6.10.5 Jiangsu Hengrui Medicine Recent Developments/Updates
• 6.11 Nanjing Pharmaceutical Factory
  • 6.11.1 Nanjing Pharmaceutical Factory Corporation Information
  • 6.11.2 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Description and Business Overview
  • 6.11.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Nanjing Pharmaceutical Factory Product Portfolio
  • 6.11.5 Nanjing Pharmaceutical Factory Recent Developments/Updates
• 6.12 Jiangsu Aosaikang Pharmaceutical
  • 6.12.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
  • 6.12.2 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Description and Business Overview
  • 6.12.3 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Jiangsu Aosaikang Pharmaceutical Product Portfolio
  • 6.12.5 Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
• 6.13 Qilu Pharmaceutical
  • 6.13.1 Qilu Pharmaceutical Corporation Information
  • 6.13.2 Qilu Pharmaceutical Platinum-based Anticancer Drugs Description and Business Overview
  • 6.13.3 Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Qilu Pharmaceutical Product Portfolio
  • 6.13.5 Qilu Pharmaceutical Recent Developments/Updates
• 6.14 Hisun Pharmaceutical
  • 6.14.1 Hisun Pharmaceutical Corporation Information
  • 6.14.2 Hisun Pharmaceutical Platinum-based Anticancer Drugs Description and Business Overview
  • 6.14.3 Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Hisun Pharmaceutical Product Portfolio
  • 6.14.5 Hisun Pharmaceutical Recent Developments/Updates
• 6.15 Luoxin
  • 6.15.1 Luoxin Corporation Information
  • 6.15.2 Luoxin Platinum-based Anticancer Drugs Description and Business Overview
  • 6.15.3 Luoxin Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Luoxin Product Portfolio
  • 6.15.5 Luoxin Recent Developments/Updates
• 6.16 Lingnan Pharmacy
  • 6.16.1 Lingnan Pharmacy Corporation Information
  • 6.16.2 Lingnan Pharmacy Platinum-based Anticancer Drugs Description and Business Overview
  • 6.16.3 Lingnan Pharmacy Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Lingnan Pharmacy Product Portfolio
  • 6.16.5 Lingnan Pharmacy Recent Developments/Updates
• 6.17 Hansoh Pharma
  • 6.17.1 Hansoh Pharma Corporation Information
  • 6.17.2 Hansoh Pharma Platinum-based Anticancer Drugs Description and Business Overview
  • 6.17.3 Hansoh Pharma Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Hansoh Pharma Product Portfolio
  • 6.17.5 Hansoh Pharma Recent Developments/Updates

7 Platinum-based Anticancer Drugs Manufacturing Cost Analysis

• 7.1 Platinum-based Anticancer Drugs Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Platinum-based Anticancer Drugs
• 7.4 Platinum-based Anticancer Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Platinum-based Anticancer Drugs Distributors List
• 8.3 Platinum-based Anticancer Drugs Customers

9 Platinum-based Anticancer Drugs Market Dynamics

• 9.1 Platinum-based Anticancer Drugs Industry Trends
• 9.2 Platinum-based Anticancer Drugs Growth Drivers
• 9.3 Platinum-based Anticancer Drugs Market Challenges
• 9.4 Platinum-based Anticancer Drugs Market Restraints

10 Global Market Forecast

• 10.1 Platinum-based Anticancer Drugs Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Platinum-based Anticancer Drugs by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Platinum-based Anticancer Drugs by Type (2022-2027)
• 10.2 Platinum-based Anticancer Drugs Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Platinum-based Anticancer Drugs by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Platinum-based Anticancer Drugs by Application (2022-2027)
• 10.3 Platinum-based Anticancer Drugs Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Platinum-based Anticancer Drugs by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Platinum-based Anticancer Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List